Atara Biotherapeutics
ATRA
#10014
Rank
ยฃ55.41 M
Marketcap
ยฃ6.15
Share price
-1.67%
Change (1 day)
-19.88%
Change (1 year)

Revenue for Atara Biotherapeutics (ATRA)

Revenue in 2026 (TTM): ยฃ16.94 Million

According to Atara Biotherapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ17.12 Million. In 2025 the company made a revenue of ยฃ89.67 Million a decrease over the revenue in the year 2024 that were of ยฃ0.10 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Atara Biotherapeutics from 2013 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) ยฃ16.94 M-81.11%
2025 ยฃ89.67 M-12.72%
2024 ยฃ0.10 B1426.9%
2023 ยฃ6.72 M-87.19%
2022 ยฃ52.54 M248.73%
2021 ยฃ15.06 M
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ImmunoGen
IMGN
ยฃ0.21 B 1,142.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
ยฃ91.69 M 435.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
ยฃ0.71 M-95.84%๐Ÿ‡ฉ๐Ÿ‡ช Germany